DCVC Bio
North America, California, United States, San Francisco
Description
DCVC Bio is a venture capital fund that invests in early-stage life science companies driven by deep-tech approaches.
Investor Profile
DCVC Bio has made 48 investments, with 8 in the past 12 months and 54% as lead.
Stage Focus
- Series A (54%)
- Series B (19%)
- Seed (13%)
- Series C (6%)
- Series Unknown (4%)
- Series D (2%)
- Convertible Note (2%)
Country Focus
- United States (92%)
- United Kingdom (4%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (2%)
- Denmark (2%)
Industry Focus
- Biotechnology
- Medical
- Therapeutics
- Pharmaceutical
- Health Care
- Biopharma
- Life Science
- Artificial Intelligence (Ai)
- Agriculture
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
